Biological Dynamics
Biological Dynamics is a leader in exosome-isolation technology committed to improving global health outcomes through innovative, automated, and scalable diagnostic platforms. Their proprietary Verita™ platform enables rapid and reliable isolation of nanoparticles and exosomes from various biofluids, supporting early disease detection, treatment response monitoring, and research advancements. The company's products, including the ExoVerita™ Pro system and ExoVita™ Pancreas test, are designed for research use to facilitate breakthroughs in oncology and other medical fields. With a focus on cutting-edge science and strategic guidance from industry leaders, Biological Dynamics aims to revolutionize diagnostics and contribute to early disease detection and personalized medicine.
Industries
Nr. of Employees
medium (51-250)
Biological Dynamics
San Diego, California, USA
Patents
Methods and devices for detection of multiple analytes from a biological sample
US-11731132-B2
View Details
Methods and devices for detection of multiple analytes from a biological sample
US-11731132-B2
View DetailsProducts
Automated cartridge-based EV isolation instrument (research-use)
Bench instrument with disposable cartridges that automates enrichment of extracellular vesicles from clinical biofluids to produce material for downstream proteomic and nucleic acid analyses; marketed for research use.
Research-use EV proteomic pancreatic cancer assay
A research-use assay applying extracellular vesicle enrichment and proteomic classification to risk-stratify pancreatic disease (for example distinguishing risk in intraductal papillary mucinous neoplasms) and support early-detection research and clinical study enrollment.
Automated cartridge-based EV isolation instrument (research-use)
Bench instrument with disposable cartridges that automates enrichment of extracellular vesicles from clinical biofluids to produce material for downstream proteomic and nucleic acid analyses; marketed for research use.
Research-use EV proteomic pancreatic cancer assay
A research-use assay applying extracellular vesicle enrichment and proteomic classification to risk-stratify pancreatic disease (for example distinguishing risk in intraductal papillary mucinous neoplasms) and support early-detection research and clinical study enrollment.
Services
Contract laboratory service to isolate and enrich extracellular vesicles from client-provided biofluid samples to enable downstream proteomic and nucleic acid analyses.
Project-based collaborations to support assay development, clinical study setup, enrollment, and analytical validation using EV-derived biomarkers and proteomic analytics.
Laboratory testing services conducted in a CLIA-certified and CAP-accredited facility for research-use assays based on extracellular vesicle analyses.
Contract laboratory service to isolate and enrich extracellular vesicles from client-provided biofluid samples to enable downstream proteomic and nucleic acid analyses.
Project-based collaborations to support assay development, clinical study setup, enrollment, and analytical validation using EV-derived biomarkers and proteomic analytics.
Laboratory testing services conducted in a CLIA-certified and CAP-accredited facility for research-use assays based on extracellular vesicle analyses.
Expertise Areas
- Early cancer detection using extracellular vesicle biomarkers
- Lab-on-chip electrokinetic EV capture and microelectrode array separation
- Proteomic biomarker discovery and classifier development
- Multiomic integration and machine learning for diagnostic classifiers
Key Technologies
- AC electrokinetic lab-on-chip (ACE)
- Microelectrode-array EV capture
- Cartridge-based automated sample preparation
- Microfluidics for nanoparticle/EV isolation
News & Updates
Biological Dynamics presented research on the feasibility of detecting exosomal TB biomarkers in serum from HIV-negative subjects.
Hoag has joined the list of customers adopting the ExoVerita Pro instrument to support exosome research and early disease detection.
The ExoLuminate Study is expanding enrollment with institutions like Dana-Farber, UC San Diego, University of Florida, and MedStar Georgetown for early pancreatic cancer detection.
A peer-reviewed publication demonstrating the effectiveness of extracellular vesicle classifiers for early pancreatic cancer detection.
A case report on early pancreatic pre-cancer detection using exosome liquid biopsy.
Research demonstrating the potential for multi-cancer detection through extracellular vesicle protein analysis.
Biological Dynamics presented research on the feasibility of detecting exosomal TB biomarkers in serum from HIV-negative subjects.
Hoag has joined the list of customers adopting the ExoVerita Pro instrument to support exosome research and early disease detection.
The ExoLuminate Study is expanding enrollment with institutions like Dana-Farber, UC San Diego, University of Florida, and MedStar Georgetown for early pancreatic cancer detection.
A peer-reviewed publication demonstrating the effectiveness of extracellular vesicle classifiers for early pancreatic cancer detection.
A case report on early pancreatic pre-cancer detection using exosome liquid biopsy.
Research demonstrating the potential for multi-cancer detection through extracellular vesicle protein analysis.